Dose-Adjusted EPOCH regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dose-Adjusted EPOCH regimen, covering 2025-06-29 to 2025-06-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma [EARLY_Phase 1]